Skip to content

Effects of L-Tyrosine and Caffeine on Performance in Elite Boxers

Effects of L-Tyrosine and Caffeine Supplementation on Cognitive, Physical, and Physiological Parameters in Elite Boxers: A Randomized Double-Blind Placebo-Controlled Crossover Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07530185
Acronym
TYCAF-BOX
Enrollment
18
Registered
2026-04-15
Start date
2026-04-01
Completion date
2027-03-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sports Performance

Keywords

L-tyrosine, Caffeine, Boxing, BDNF, Cognitive performance, Anaerobic performance

Brief summary

Participants will complete five sessions, including one familiarization and baseline session and four experimental conditions (placebo, L-tyrosine, caffeine, and combined supplementation). The baseline session will include resting measurements. The experimental conditions will be performed in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions.

Detailed description

Participants will attend five sessions in total. The first session will be used for familiarization and baseline measurements, including resting physiological and cognitive assessments. The remaining four sessions will consist of randomized experimental conditions (placebo, L-tyrosine, caffeine, and combined supplementation), applied in a counterbalanced crossover design. Each experimental session will be separated by a washout period of at least 72 hours. Supplements will be administered 60 minutes before exercise. Cognitive performance will be assessed using the Stroop test, and physical performance will be evaluated using a boxing-specific simulation protocol. Physiological responses, including heart rate and biochemical markers such as BDNF and oxidative stress parameters, will be measured.

Interventions

DIETARY_SUPPLEMENTPlacebo

Placebo solution matched in taste and volume to active supplements.

DIETARY_SUPPLEMENTL-Tyrosine

L-tyrosine at 150 mg/kg body weight administered 60 minutes before exercise.

DIETARY_SUPPLEMENTCaffeine

Caffeine at 5 mg/kg body weight administered 60 minutes before exercise.

DIETARY_SUPPLEMENTL-tyrosine + Caffeine

Combined L-tyrosine (150 mg/kg) and caffeine (5 mg/kg) administered 60 minutes before exercise.

Sponsors

Inonu University
Lead SponsorOTHER
Ataturk University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Both participants and investigators are blinded to the supplementation conditions. Supplements are prepared and coded by an independent researcher to ensure double-blind conditions.

Intervention model description

Participants will complete four experimental conditions (placebo, L-tyrosine, caffeine, and combined supplementation) in a randomized, counterbalanced crossover design with a washout period of at least 72 hours between sessions.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Male elite boxers aged ≥18 years At least 8 years of boxing training experience Active participation in national or international competitions Regular training schedule No injury or illness affecting performance

Exclusion criteria

Use of nutritional supplements or stimulants within the last 4 weeks Any cardiovascular, metabolic, or neurological disorder Current injury or musculoskeletal limitation Smoking or excessive caffeine intake Failure to comply with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Stroop Test Performanceup to 12 weeksCognitive performance assessed using the Stroop test, including reaction time and accuracy.

Secondary

MeasureTime frameDescription
BDNF Levelsup to 12 weeksSerum brain-derived neurotrophic factor levels measured before and after exercise.
Oxidative Stress Markersup to 12 weeksSerum levels of total antioxidant status (TAS), total oxidant status (TOS), malondialdehyde (MDA), superoxide dismutase (SOD) activity, and glutathione peroxidase (GPx) activity will be measured.

Countries

Turkey (Türkiye)

Contacts

CONTACTHalil UÇAR
halil.ucar@inonu.edu.tr+90 5462921133

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026